Influence of gastritis on cyclooxygenase-2 expression before and after eradication of Helicobacter pylori infection

被引:13
作者
Wambura, C
Aoyama, N
Shirasaka, D
Kuroda, K
Maekawa, S
Ebara, S
Watanabe, Y
Tamura, T
Kasuga, M
机构
[1] Kobe Univ, Dept Endoscopy, Grad Sch Med, Kobe, Hyogo 6500017, Japan
[2] Kobe Univ, Dept Clin Mol Med, Grad Sch Med, Div Diabet Digest & Kidney Dis, Kobe, Hyogo 6500017, Japan
关键词
gastritis; cyclooxygenase-2; expression; Helicobacter pylori eradication;
D O I
10.1097/00042737-200410000-00004
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives Helicobacter pylori infection causes chronic gastritis and induces cyclooxygenase (COX)-2 expression. The relationship between gastritis and COX-2 expression is not well understood, especially long after the organism has been eradicated. We designed a study to elucidate this relationship. Methods Four endoscopic gastric biopsies from each of 118 H. pylori-infected subjects were assessed for COX-2 expression immunohistochemically, gastritis, by an updated Sydney System. In the 107 successfully eradicated subjects, the assessment was repeated once yearly, for 3 years. Results After successful eradication, COX-2 expression was reduced significantly regardless of site. Atrophy improved significantly and intestinal metaplasia improved but not in the antrum greater curvature. After 1 year COX-2 expression was not significantly different in the epithelia with and without intestinal metaplasia. Correlation between COX-2 expression and neutrophil score in the antrum (r= 0.214, P= 0.042) and inflammation in the corpus (r= 0.234, P= 0.025) disappeared after eradication. COX-2 expression correlated well with atrophy and metaplasia before and after eradication. No significant reduction in COX-2 or improvement in gastritis was found in subjects with eradication failure. Conclusion H. pylori infection is associated with the enhancement of COX-2 expression in the gastric mucosa. Eradication therapy reduces COX-2 expression and hence may reduce the risk of cancer development.
引用
收藏
页码:969 / 979
页数:11
相关论文
共 40 条
[1]  
Annibale B, 2000, ALIMENT PHARM THERAP, V14, P625
[2]  
Ciok J, 1997, J Physiol Pharmacol, V48 Suppl 4, P115
[3]  
CORREA P, 1975, LANCET, V2, P58
[4]  
CORREA P, 1990, CANCER-AM CANCER SOC, V66, P2569, DOI 10.1002/1097-0142(19901215)66:12<2569::AID-CNCR2820661220>3.0.CO
[5]  
2-I
[6]   Classification and grading of gastritis - The updated Sydney System [J].
Dixon, MF ;
Genta, RM ;
Yardley, JH ;
Correa, P ;
Batts, KP ;
Dahms, BB ;
Filipe, MI ;
Haggitt, RC ;
Haot, J ;
Hui, PK ;
Lechago, J ;
Lewin, K ;
Offerhaus, JA ;
Price, AB ;
Riddell, RH ;
Sipponen, P ;
Solcia, E ;
Watanabe, H .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (10) :1161-1181
[7]  
EBHERHAT CE, 1994, GASTROENTEROLOGY, V107, P1183
[8]   ASSOCIATION BETWEEN INFECTION WITH HELICOBACTER-PYLORI AND RISK OF GASTRIC-CANCER - EVIDENCE FROM A PROSPECTIVE INVESTIGATION [J].
FORMAN, D ;
NEWELL, DG ;
FULLERTON, F ;
YARNELL, JWG ;
STACEY, AR ;
WALD, N ;
SITAS, F .
BRITISH MEDICAL JOURNAL, 1991, 302 (6788) :1302-1305
[9]   Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis [J].
Fu, SD ;
Ramanujam, KS ;
Wong, A ;
Fantry, GT ;
Drachenberg, CB ;
James, SP ;
Meltzer, SJ ;
Wilson, KT .
GASTROENTEROLOGY, 1999, 116 (06) :1319-1329
[10]  
GENTA RM, 1993, MODERN PATHOL, V6, P281